Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$762K Sell
4,662
-1,436
-24% -$221K 0.01% 1654
2025
Q4
$1.06M Buy
+6,098
New +$1.11M 0.03% 987
2025
Q3
Sell
-56,380
Closed -$5.67M 2881
2025
Q2
$5.67M Buy
56,380
+35,130
+165% +$2.69M 0.24% 58
2025
Q1
$1.62M Buy
+21,250
New +$1.63M 0.08% 327
2024
Q2
Sell
-33,500
Closed -$909K 2143
2024
Q1
$909K Buy
+33,500
New +$938K 0.12% 199
2023
Q4
Sell
-9,327
Closed -$236K 1825
2023
Q3
$236K Buy
+9,327
New +$213K 0.04% 912
2023
Q1
Sell
-10,314
Closed -$206K 1461
2022
Q4
$206K Buy
+10,314
New +$199K 0.04% 827
2021
Q4
Sell
-12,561
Closed -$346K 835
2021
Q3
$346K Buy
+12,561
New +$330K 0.12% 302

Other funds holding INSM

XTX Topco's INSM Position: Q1 2026 in Review

XTX Topco reduced its Insmed (INSM) stake by 24% in Q1 2026, selling an estimated $221K and leaving 4,662 shares worth $762K. The position accounts for 0.01% of the portfolio, ranked #1654.

XTX Topco first reported a position in INSM in Q3 2021 and has held it in 8 quarters since. The position peaked at $5.67M in Q2 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • XTX Topco held 4,662 shares of Insmed worth $762K as of Q1 2026.
  • XTX Topco sold 1,436 Insmed shares in Q1 2026, an estimated $221K.
  • Insmed made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1654 holding.
  • XTX Topco first reported a position in Insmed in Q3 2021 and has held it in 8 quarters since.
  • XTX Topco's Insmed position peaked at $5.67M in Q2 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.